PRAS Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV) (UDI AS-549)
Manufactured by ANAEROBE SYSTEMS
Device Regulatory Overview
The PRAS Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV) (Model/Catalog Number: AS-549) is a medical device manufactured by ANAEROBE SYSTEMS. This product is indexed under FDA Product Code / Category Classification JSI within international Unique Device Identification (UDI) compliance databases.
Technical Specifications
- Model Number
- AS-549
- Product Code / EMDN
- JSI
- Device Name
- AS-549 Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV) is an enriched, selective, and differential medium intended for the cultivation and isolation of most gram-negative anaerobic and other fastidious bacteria. Pre-reduced anaerobically sterilized (PRAS). 100 x 15 mm agar plate. Transparent yellow/red. 4 plates per pack.
- Database Sync Date
- 2026-08-09 09:10:00
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of PRAS Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV)?
The registered manufacturer of record for PRAS Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV) is ANAEROBE SYSTEMS.
What is the Primary UDI-DI identifier for PRAS Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV)?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is AS-549.
What classification code is assigned to this device?
This device is registered under product classification code JSI.
Similar Classification Devices (JSI)
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint